[The preliminary clinical results of laparoscopic ileum augmentation cystoplasty for XXXX ].

@entity1 @entity295 @entity1494 @entity548 @entity190 @entity4358 @entity602 @entity3041 @entity1320 @entity10020 @entity1011 @entity1566 @entity378 @entity130
OBJECTIVE: To study the effectiveness and safety of the laparoscopic ileal bladder augmentation treatment for @entity1494 . METHODS: A retrospective analysis was performed based on 36 cases admitted to the Zhejiang Provincial @entity1 's Hospital with highly reflective and @entity1494 accepted laparoscopic ileal bladder augmentation surgical treatment from June 2011 to December 2013. In accordance with inclusion and exclusion criteria, 22 @entity1 were enrolled in this study, including 13 males, 9 females who aged from 22 to 62 years with an average of 35.8 years. Among the selected sample, there were 15 cases of @entity1566 , 4 cases of @entity602 , and 3 cases of @entity378 . The duration of disease varied from 1 to 15 years, with an average of 8.5 years. For surgery, intraoperative and perioperative complications were observed, and preoperative serum @entity1011 in @entity1 with postoperative at 3, 6, 12, 18, 24, 36 months, @entity3041 , and glomerular filtration rate urodynamic parameters were used for univariate analysis of variance. RESULTS: All @entity1 were successfully completed in laparoscopic surgery, the operative time were (105    17) minutes (90-150 minutes), @entity190 was (90    26) ml (60-150 ml), postoperative intestinal function recovery time were (2.5    0.7) d (2-5 d), and postoperative hospital stay was (15.0    4.2) d (11-20 d), while postoperative anastomotic leakage, intestinal blockage, severe @entity1320 or @entity295 and other complications did not occur. @entity1 were followed up for 6 to 36 months, with an average of 16.5 months, among which 17 @entity1 were followed up for over 12 months. The bladder safety capacity increased from (103    38) ml preoperatively to (405    46) ml at the end of the follow-up (F = 381.7, P = 0.000), and bladder compliance increased from (10    3) cm @entity4358 (1 cmH2O = 0.098 kPa) preoperatively to (38    4) @entity10020 O (F = 678.1, P = 0.000); the average pressure within the bladder filling at the end of the follow-up was (16    6) cm @entity4358 , which was significantly lower (F = 221.5, P = 0.000) compared to preoperative level of (45    16) cm @entity4358 , preoperative serum @entity1011 went down from (184    32)   mol/L to (120    28)   mol/L at the end of the follow-up (F = 189.1, P = 0.000); total glomerular filtration rate rose from (40    26) ml(-1)    min(-1)    1.73 m(-2) preoperatively to (66    32) ml(-1)    min(-1)    1.73 m(-2) (F = 137.7, P = 0.000). Qmax of the 3 cases of @entity1494 contracture @entity378 @entity1 increased significantly, while 4 female @entity1 with residual urine volume decrease had voluntary urination. CONCLUSIONS: Laparoscopic ileal bladder augmentation treatment for @entity1494 is feasible and safe, with less @entity130 , less @entity548 , less post-operative complications, and faster recovery of bowel function. Urinary function improves significantly after surgery, and function of upper urinary tract can also be effectively improved and protected in @entity1 .
